Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Jun;30(3):230-234.
doi: 10.1177/1971400917691993. Epub 2017 Apr 5.

Performance of apparent diffusion coefficient of medial and lateral rectus muscles in Graves' orbitopathy

Affiliations

Performance of apparent diffusion coefficient of medial and lateral rectus muscles in Graves' orbitopathy

Ahmed Ak Abdel Razek et al. Neuroradiol J. 2017 Jun.

Abstract

Objective The purpose of this study was to determine the performance of the apparent diffusion coefficient in the detection of involvement of the medial and lateral rectus muscles in patients with Graves' orbitopathy. Methods and materials This prospective study was conducted on 33 consecutive patients (16 males, 17 females with a mean age of 36 years) with Graves' orbitopathy and 18 age- and sex-matched volunteers. The patients and volunteers underwent diffusion-weighted magnetic resonance imaging of the orbit in the axial plane using echo-planar imaging. The apparent diffusion coefficient of the medial and lateral rectus muscles was calculated. Results The medial rectus muscle was more affected than the lateral rectus muscle. The mean apparent diffusion coefficient value of the medial and lateral rectus muscles was 1.81 ± 0.19 and 1.72 ± 0.07 × 10-3 mm2/s in patients with Graves' orbitopathy and 1.59 ± 0.06 and 1.51 ± 0.06 × 10-3 mm2/s in volunteers, respectively. There was a significant difference in apparent diffusion coefficient values of the medial and lateral rectus muscles between patients with Graves' orbitopathy and volunteers ( p = 0.001). The classification performance as measured with area under the receiver operator characteristic curve was 0.89 (95% confidence interval: 0.732-0.904). The best performing threshold of the apparent diffusion coefficient value of the medial rectus muscle was 1.69 × 10-3 mm2/s and associated efficiency was 86%, sensitivity was 97%, and specificity was 97%. Conclusion We concluded that the apparent diffusion coefficient of the medial rectus muscle can be used for diagnosis of Graves' orbitopathy.

Keywords: Diffusion; Graves; magnetic resonance imaging; orbit.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Graves' orbitopathy: (a) axial T2-weighted image of the orbit shows enlarged both medial and lateral rectus muscles; (b) axial ADC map shows localization of the ROI within the mid part of the medial and lateral rectus muscles. The ADC of the medial rectus muscle is 1.93 × 10−3 mm2/s and of the lateral rectus muscle is 1.77 × 10−3 mm2/s. ADC: apparent diffusion coefficient; ROI: region of interest.
Figure 2.
Figure 2.
Volunteers: (a) axial T2-weighted image of the orbit shows normal size of medial and lateral rectus muscles; (b) axial ADC map shows localization of the ROI within the mid part of the medial and lateral rectus muscles. The ADC of the medial rectus muscle is 1.52 × 10−3 mm2/s and of the lateral rectus muscle is 1.47 × 10−3 mm2/s. ADC: apparent diffusion coefficient; ROI: region of interest.
Figure 3.
Figure 3.
ROC curve. The cut-off ADC value of medial rectus used for differentiation of patients with Graves' orbitopathy from volunteers was 1.69 × 10−3 mm2/s with AUC 0.89 ± 0.09, 95% CI 0.732–0.904, accuracy of 86%, sensitivity of 97% and specificity of 97%. ROC: receiver operating characteristic; ADC: apparent diffusion coefficient; AUC: area under the curve.

References

    1. Hiromatsu Y, Wall JR, Kahaly GJ, et al. Graves' orbitopathy. Int J Endocrinol 2015; 2015: 634234. - PMC - PubMed
    1. Cockerham KP, Chan SS. Thyroid eye disease. Neurol Clin 2010; 28: 729–755. - PubMed
    1. Bahn RS. Current insights into the pathogenesis of Graves' ophthalmopathy. Horm Metab Res 2015; 47: 773–778. - PubMed
    1. Shan SJ, Douglas RS. The pathophysiology of thyroid eye disease. J Neuroophthalmol 2014; 34: 177–185. - PubMed
    1. Barrio-Barrio J, Sabater AL, Bonet-Farriol E, et al. Graves' ophthalmopathy: VISA versus EUGOGO classification, assessment, and management. J Ophthalmol 2015; 2015: 249125. - PMC - PubMed

LinkOut - more resources